Table of Contents

company-logo

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

NeoGenomics Dividend Announcement

• NeoGenomics announced a annually dividend of $0.40 per ordinary share which will be made payable on 2020-12-30. Ex dividend date: 2020-12-17
• NeoGenomics's trailing twelve-month (TTM) dividend yield is -%

NeoGenomics Dividend History

Ex-Div dateDividend amountDividend typePay date
2020-12-17$0.40annually2020-12-30

NeoGenomics Dividend per year

NeoGenomics Dividend Yield

NeoGenomics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NeoGenomics stock? Use our calculator to estimate your expected dividend yield:

NeoGenomics Financial Ratios

P/E ratio-22.76
PEG ratio-0.24
P/B ratio1.95
ROE-8.43%
Payout ratio0.00%
Current ratio2.01
Quick ratio1.93
Cash Ratio1.22

NeoGenomics Dividend FAQ

Does NeoGenomics stock pay dividends?
NeoGenomics does not currently pay dividends to its shareholders.
Has NeoGenomics ever paid a dividend?
No, NeoGenomics has no a history of paying dividends to its shareholders. NeoGenomics is not known for its dividend payments.
Why doesn't NeoGenomics pay dividends?
There are several potential reasons why NeoGenomics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NeoGenomics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NeoGenomics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NeoGenomics a dividend aristocrat?
NeoGenomics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NeoGenomics a dividend king?
NeoGenomics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NeoGenomics a dividend stock?
No, NeoGenomics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NeoGenomics stocks?
To buy NeoGenomics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NeoGenomics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.